With over 900,000 US patients undergoing bone-related surgeries each year, a New York based start-up called EpiBone wants to simplify how we construct new bone. Their technology, while still being tested, is a revolutionary procedure that utilizes a patients' own stem cells to engineer a personalized bone graft, giving surgeons simplified procedures and patients highly accurate bone formation and regeneration without the complication of synthetic implants.
By day, Jack Andraka appears to be a normal high school student. But after school, he goes to the lab at Johns Hopkins, where he’s developing a test for pancreatic cancer that is worlds better than what’s currently available. In this video, see him talk about his breakthrough.